Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 4


Figure 4 Effect of Beta-Blockers on Anti-ß1-Abs–Induced Receptor Activation

Beta-blockers do not fully abolish the Epac-FRET signals in cells stimulated with high-activator anti-ß1-Abs. Neither the selective ß1-AR anatagonists bisoprolol (Biso) (A) or metoprolol (Meto), nor nonselective drugs such as alprenolol (C) (Alpren) or carvedilol (Carved) blocked more than 70% of the FRET response induced by high-activator IgG under saturating conditions (3 µmol/l). Bisoprolol combined with ECII peptides, however, could fully block high-activator-induced FRET signals (Biso + ECII) (D). (B) Concentration-response curve for the inhibitory effect of bisoprolol alone on high-activator-induced FRET signals. Data, means, and SEMs in (D) are calculated from at least 4 independent experiments. (E) The stimulatory effect of low-activator IgG could be fully abolished by bisoprolol. Representative experiments, n = 6. Quantification is shown in (F) together with the effect of a combination of bisoprolol with ECI peptides (n = 5). Abbreviations as in Figures 1 and 2.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement